EFFICACY OF GENERIC DRUG WARTOCID® (IMIQUIMOD 5% CREAM FOR EXTERNAL USE) IN ANOGENITAL WARTS TREATMENT
Aim. To evaluate the efficacy and safety of the generic drug Wartocid® (Imiquimod cream 5% for external use) in patients with external anogenital (venereal) warts (AGW). Materials and methods. The single-blind comparative, randomized, placebo-controlled clinical trial included 50 women aged 18 to 60...
Guardado en:
Autores principales: | V. S. Smirnova, S. V. Petlenkoa, S. A. Savelyeva, G. Redlichb, N. I. Stukana |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/580c8dee77b249159e713b4314875a6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Myriam Berrada, et al.
Publicado: (2021) -
Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Noha M. Hammad, et al.
Publicado: (2021) -
Cryotherapy versus CO2 laser in the treatment of plantar warts: a randomized controlled trial
por: Nahid Hemmatian Boroujeni, et al.
Publicado: (2018) -
Human papillomavirus infection with anogenital warts in a patient with chronic psoriasis: A case report
por: Wu‐Feng Hsieh, et al.
Publicado: (2021) -
Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Kerasia‐Maria Plachouri, et al.
Publicado: (2021)